References
- Aggarwal BB (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell, 6, 203-8. https://doi.org/10.1016/j.ccr.2004.09.003
- Andrews NC, Faller DV (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res, 19, 2499. https://doi.org/10.1093/nar/19.9.2499
- Basseres DS, Baldwin AS (2006). Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene, 25, 6817-30. https://doi.org/10.1038/sj.onc.1209942
- Blechacz B, Komuta M, Roskams T, Gores GJ (2011). Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol, 8, 512-22. https://doi.org/10.1038/nrgastro.2011.131
- Boberg KM, Schrumpf E (2004). Diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep, 6, 52-9. https://doi.org/10.1007/s11894-004-0026-1
- Charbel H, Al-Kawas FH (2012). Cholangiocarcinoma treatment. Curr Gastroenterol Rep, 14, 528-33. https://doi.org/10.1007/s11894-012-0286-0
- Chen JZ, Zhu JH, Wang XX, et al (2004). Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol, 36, 233-9. https://doi.org/10.1016/j.yjmcc.2003.10.005
- Chiang AC, Massague J (2008). Molecular basis of metastasis. N Engl J Med, 359, 2814-23. https://doi.org/10.1056/NEJMra0805239
- Cho HJ, Lee TS, Park JB, et al (2007). Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol, 40, 1069-76. https://doi.org/10.5483/BMBRep.2007.40.6.1069
- Cvek B, Dvorak Z (2007). Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals. Curr Pharm Des, 13, 3155-67. https://doi.org/10.2174/138161207782110390
- Dasanu CA, Majumder S, Trikudanathan G (2011). Emerging pharmacotherapeutic strategies for cholangiocarcinoma. Expert Opin Pharmacother, 12, 1865-74. https://doi.org/10.1517/14656566.2011.583919
- Eneanya DI, Bianchine JR, Duran DO, Andresen BD (1981). The actions of metabolic fate of disulfiram. Annu Rev Pharmacol Toxicol, 21, 575-96. https://doi.org/10.1146/annurev.pa.21.040181.003043
- Goto H, Kariya R, Shimamoto M, et al (2012). Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-kappaB pathway. Cancer Sci, 103, 775-81. https://doi.org/10.1111/j.1349-7006.2012.02212.x
- Hu XS, Du CQ, Yang L, Yao XY, Hu SJ (2010). Proteasome inhibitor MG132 suppresses number and function of endothelial progenitor cells: involvement of nitric oxide synthase inhibition. Int J Mol Med, 25, 385-92.
- Janan M, Proungvitaya S, Limpaiboon T, Proungvitaya T, Roytrakul S, et al (2012). Serum adhesion molecule-1 (icam- 1) as a potential prognostic marker for cholangiocarcinoma patients. Asian Pac J Cancer Prev, 13, 107-14.
- Langeland BT, McKinley-McKee JS (1996). The effects of disulfiram on equine hepatic alcohol dehydrogenase and its efficiency against alcoholism: vinegar effect. Alcohol Alcohol, 31, 75-80. https://doi.org/10.1093/oxfordjournals.alcalc.a008120
- Liang CC, Park AY, Guan JL (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc, 2, 329-33. https://doi.org/10.1038/nprot.2007.30
- Lovborg H, Oberg F, Rickardson L, et al (2006). Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram. Int J Cancer, 118, 1577-80. https://doi.org/10.1002/ijc.21534
- Margineanu E, Cotrutz CE, Cotrutz C (2008). Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi, 112, 432-6.
- Maruo Y, Gochi A, Kaihara A, et al (2002). ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer, 100, 486-90. https://doi.org/10.1002/ijc.10514
- Matsuno T, Kariya R, Yano S, et al (2012). Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-kappaB pathway. Int J Oncol, 40, 1071-8.
- Murai R, Yoshida Y, Muraguchi T, et al (2010). A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs. Oncotarget, 1, 252-64.
- Pande V, Ramos MJ (2005). NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem, 12, 357-74. https://doi.org/10.2174/0929867053363180
- Pang H, Chen D, Cui QC, Dou QP (2007). Sodium diethyldithiocarbamate, an AIDS progression inhibitor and a copper-binding compound, has proteasome-inhibitory and apoptosis-inducing activities in cancer cells. Int J Mol Med, 19, 809-16.
- Rosette C, Roth RB, Oeth P, et al (2005). Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis, 26, 943-50.
- Schurigt U, Stopfel N, Huckel M, et al (2005). Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis. Arthritis Res Ther, 7, 174-88. https://doi.org/10.1186/ar1466
- Seubwai W, Vaeteewoottacharn K, Hiyoshi M, et al (2010). Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Cancer Sci, 101, 1590-5. https://doi.org/10.1111/j.1349-7006.2010.01572.x
- Shian SG, Kao YR, Wu FY, Wu CW (2003). Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol, 64, 1076-84. https://doi.org/10.1124/mol.64.5.1076
- Skrott Z, Cvek B (2012). Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells. Mini Rev Med Chem, 12, 1184-92. https://doi.org/10.2174/138955712802762068
- Suh JJ, Pettinati HM, Kampman KM, O'Brien CP (2006). The status of disulfiram: a half of a century later. J Clin Psychopharmacol, 26, 290-302. https://doi.org/10.1097/01.jcp.0000222512.25649.08
- Tang X, Li J, Xin X, Geng M (2006). A new marine-derived sulfated polysaccharide from brown alga suppresses tumor metastasis both in vitro and in vivo. Cancer Biol Ther, 5, 1474-80.
- Uthaisar K, Seubwai W, Srikoon P, Vaeteewoottacharn K, Sawanyawisuth K, et al (2012). Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines. Asian Pac J Cancer Prev, 13, 149-54.
- Wang F, Zhai S, Liu X, et al (2011). A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosisinducing activity in human breast cancer cells. Cancer Lett, 300, 87-95. https://doi.org/10.1016/j.canlet.2010.09.010
- Zhang JJ, Xu ZM, Zhang CM, et al (2011). Pyrrolidine dithiocarbamate inhibits nuclear factor-kappaB pathway activation, and regulates adhesion, migration, invasion and apoptosis of endometriotic stromal cells. Mol Hum Reprod, 17, 175-81. https://doi.org/10.1093/molehr/gaq090
Cited by
- Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5617
- In vitro and In vivo Antitumor Activity of Tiliacorinine in Human Cholangiocarcinoma vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7473
- Current Insights on Cholangiocarcinoma Research: a Brief Review vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1307
- Effect of NF-κB inhibition on chemoresistance in biliary–pancreatic cancer vol.45, pp.12, 2015, https://doi.org/10.1007/s00595-015-1129-z
- The role of tumour microenvironment: a new vision for cholangiocarcinoma pp.15821838, 2019, https://doi.org/10.1111/jcmm.13953